Since 1998, he has been developing molecular tools for diagnostics and epidemiology of leishmaniases. Beyond publishing new methods, he has extensively invested in standardization of the developed tools, quality assurance and dissemination. As a result, many laboratories in the world have adopted the developed methods for genotyping and molecular epidemiology.